SMOKING CESSATION TREATMENTS: CURRENT PSYCHOLOGICAL AND PHARMACOLOGICAL OPTIONS.
Rev Invest Clin
; 71(1): 7-16, 2019.
Article
em En
| MEDLINE
| ID: mdl-30810545
ABSTRACT
BACKGROUND:
Smoking is considered an epidemic, indeed, one of the most important public health problems worldwide. It is also the most significant preventable cause of death, of a high number of premature deaths, and avoidable chronic diseases. It is considered an enormous economic burden for the world.OBJECTIVE:
To provide an overview of smoking-cessation treatments, including pharmacological and psychological options, and to gather current scientific evidence available on them.METHODS:
Research included reviewing publications from 2007-2018 in four databases using algorithms related to bupropion, varenicline, nicotine replacement therapy, smoking cessation, psychological treatment, motivational interview, cognitive-behavioral therapy and clinical guidelines for smoking treatment. Meta-analyses or systematic reviews and randomized or quasi-randomized trials were selected. We also included clinical guidelines for smoking treatment from Mexico and other countries.RESULTS:
After refining the search, 37 articles met the criteria and were included in the review. The results were grouped by type of intervention.CONCLUSIONS:
It is necessary to conduct research on combinations of both kinds of treatment with an integral, multidisciplinary vision. Current standard for smoking cessation is a combined psychological and pharmacological treatment.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Abandono do Hábito de Fumar
/
Guias de Prática Clínica como Assunto
/
Dispositivos para o Abandono do Uso de Tabaco
Tipo de estudo:
Clinical_trials
/
Guideline
/
Qualitative_research
Limite:
Humans
País/Região como assunto:
Mexico
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article